English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jun 11, 2026

Swedish researchers develop AI model to accelerate molecular simulations in drug discovery
+ Pharmaceuticals
Patient Daily | Jun 11, 2026

Parabilis and Kailera set biotech IPO records amid renewed market interest
+ Pharmaceuticals
Patient Daily | Jun 11, 2026

Takeda’s investigational pill outperforms Sotyktu in Phase 3 psoriasis trial
+ Pharmaceuticals
Patient Daily | Jun 11, 2026

Novartis extends partnership with Orionis in molecular glue deal worth up to $1.4 billion
+ Pharmaceuticals
Patient Daily | Jun 11, 2026

Study finds low-dose atropine drops slow myopia progression in UK children
+ Pharmaceuticals
Patient Daily | Jun 11, 2026

Article compares AI errors to human confabulations and hallucinations in psychiatry
+ Pharmaceuticals
Patient Daily | Jun 11, 2026

FDA accepts Genentech’s immunotherapy drug for review in stage III colon cancer
+ Pharmaceuticals
Patient Daily | Jun 11, 2026

Childhood lead exposure declines but disparities remain, study finds

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes